Table 5.
The influence of PES1 (P) on cardiovascular diseases.
| circRNA | miRNA (P/N) | MRNA (P/N) | Effect |
|---|---|---|---|
| circANRIL | — | PES1 (P) | AS [55] |
| CDR1as | miR-7a (P) | PARP, SP1 (P) | Myocardial infarction [56] |
| circRNA-HRCR | miR-223 (N) | ARC (P) | Myocardial hypertrophy [57] |
| MFACR | miR-625-3p (N) | MTP18 (N) | Apoptosis [58] |
| circRNA_010567 | miR-141 (N) | TGF-β1 (P) | Myocardial fibrosis [25] |
| circNCX1 | miR-133a-3p (N) | CDIP1 (P) | Apoptosis [59] |
| Circ-SATB2 | miR-939 (N) | STIM1 (P) | Cell proliferation and differentiation [60] |
| circCHFR | miR-370 (N) | FOXO1/Cyclin D1 (N) | Migration of vascular smooth muscle [61] |
| circSlc8a1 | miR-133a (N) | SRF, CTGF, Adrb1, Adcy6 (P) | Myocardial hypertrophy [62] |
| circNfix | miR-214 (N) | Gsk3β (P) | Cardiac regeneration [63] |
| circHIPK3 | miR-29b-3p (N) | a-SMA, COL1A1, COL3A1 (N) | Cardiac fibroblasts [64] |
P/N: positive regulation or negative regulation.